Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

20. April 2004 16:35 ET | Quelle: Swiss Medica, Inc.

Biotech Stock Review Issues Coverage On Swiss Medica

TORONTO, April 20, 2004 (PRIMEZONE) -- Swiss Medica Inc., (OTCBB:SWME) announced today that the Biotech Stock Review has recently added it to its Watch List and issued a Corporate Profile on the...
20. April 2004 13:36 ET | Quelle: QT 5, Inc.

QT 5, Inc. Announces Shareholder Approval of 1:10 Reverse Stock Split

WESTLAKE VILLAGE, Calif., April 20, 2004 (PRIMEZONE) -- QT 5, Inc. (OTCBB:QTFV), manufacturer, distributor and marketer of biomedical products, today announced that it has obtained shareholder...
20. April 2004 12:24 ET | Quelle: Cytomedix, Inc.

Cytomedix, Inc. Names Dr. Kshitij Mohan New Chief Executive Officer

LITTLE ROCK, Ark., April 20, 2004 (PRIMEZONE) -- Cytomedix, Inc. (OTCBB:CYME) today announced the appointment of Kshitij Mohan, Ph.D. as its new chief executive officer, filling a position that has...
14. April 2004 14:37 ET | Quelle: HepaLife Technologies, Inc.

HepaLife Approved for Listing on Berlin Bremen Exchange

VANCOUVER, B.C., April 14, 2004 (PRIMEZONE) -- HepaLife Technologies, Inc. (OTCBB:HPLF) is pleased to announce that effective immediately the Company has been approved for dual listing on the Berlin...
13. April 2004 08:30 ET | Quelle: CalbaTech, Inc.

CalbaTech Announces University of California, Irvine Cooperative Research Program Hits Technical Milestone in Development of Respiratory Pathogen Chip

IRVINE, Calif., April 13, 2004 (PRIMEZONE) -- CalbaTech, Inc. (OTCBB:CLBE), an emerging life sciences company (http://www.CalbaTech.com) concentrating on providing products and platforms to the...
08. April 2004 13:54 ET | Quelle: MIR Preclinical Services

Molecular Therapeutics, Inc. announces the formation of Molecular Imaging Products Company

ANN ARBOR, Mich., April 8, 2004 (PRIMEZONE) -- Molecular Therapeutics, Inc. (MRx) today announced the formation of Molecular Imaging Products Company (MIP), which will focus on the manufacture and...
07. April 2004 14:08 ET | Quelle: Cobalis Corp

BioGentech's Trading Symbol Erroneously Receives "E"

IRVINE, Calif., April 7, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a pharmaceutical company specializing in over-the-counter anti-allergy medications, today announced that the letter "E" it...
05. April 2004 08:00 ET | Quelle: Bio-Life Laboratories

Bio-life Laboratories Corporation Completes Reverse Merger Transaction With Tecscan International, Inc.

LOS ANGELES, April 5, 2004 (PRIMEZONE) -- Bio-Life Laboratories Corporation ("Bio-life") announced today that it has become a wholly owned subsidiary of Tecscan International, Inc. ("TecScan")...
02. April 2004 13:53 ET | Quelle: Discovery Laboratories, Inc.

Discovery Laboratories Announces Completion of Underwritten Offering of Common Stock

DOYLESTOWN, Pa., April 2, 2004 (PRIMEZONE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced the completion of its previously announced underwritten public offering of 2,200,000 shares of...
01. April 2004 07:30 ET | Quelle: Cytomedix, Inc.

Cytomedix, Inc. Completes $4.5 Million Private Placement

LITTLE ROCK, Ark., April 1, 2004 (PRIMEZONE) -- Cytomedix, Inc. (OTCBB:CYME) today announced it has completed a private placement raising $4.5 million in gross proceeds. Additional information...

Vorherige Seite

Nächste Seite